The purpose of this legislation, known as the Open Payments Expansion Act, is to enhance transparency regarding financial relationships between pharmaceutical and medical device manufacturers and patient advocacy organizations. The main objective is to require these manufacturers to publicly disclose any payments they make to these organizations, which can help ensure accountability and trust in the healthcare system.